Stella Pharma Corporation (TYO:4888)

Stella Pharma Statistics

Total Valuation

Stella Pharma has a market cap or net worth of JPY 16.00 billion. The enterprise value is 14.09 billion.

Market Cap	16.00B
Enterprise Value	14.09B

Important Dates

The last earnings date was Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Stella Pharma has 34.03 million shares outstanding. The number of shares has increased by 4.11% in one year.

Current Share Class	34.03M
Shares Outstanding	34.03M
Shares Change (YoY)	+4.11%
Shares Change (QoQ)	-0.01%
Owned by Insiders (%)	4.28%
Owned by Institutions (%)	-0.78%
Float	20.83M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.52
PB Ratio	5.94
P/TBV Ratio	6.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-50.51
EV / Sales	14.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.77, with a Debt / Equity ratio of 0.29.

Current Ratio	18.77
Quick Ratio	13.21
Debt / Equity	0.29
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-38.00

Financial Efficiency

Return on equity (ROE) is -9.84% and return on invested capital (ROIC) is -3.92%.

Return on Equity (ROE)	-9.84%
Return on Assets (ROA)	-2.89%
Return on Invested Capital (ROIC)	-3.92%
Return on Capital Employed (ROCE)	-5.03%
Weighted Average Cost of Capital (WACC)	10.51%
Revenue Per Employee	22.51M
Profits Per Employee	-6.49M
Employee Count	43
Asset Turnover	0.20
Inventory Turnover	0.09

Taxes

In the past 12 months, Stella Pharma has paid 2.00 million in taxes.

Income Tax	2.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.17% in the last 52 weeks. The beta is 1.23, so Stella Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.23
52-Week Price Change	+12.17%
50-Day Moving Average	312.54
200-Day Moving Average	344.71
Relative Strength Index (RSI)	65.12
Average Volume (20 Days)	1,748,455

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Stella Pharma had revenue of JPY 968.00 million and -279.00 million in losses. Loss per share was -8.20.

Revenue	968.00M
Gross Profit	850.00M
Operating Income	-228.00M
Pretax Income	-277.00M
Net Income	-279.00M
EBITDA	-194.75M
EBIT	-228.00M
Loss Per Share	-8.20

Balance Sheet

The company has 2.69 billion in cash and 786.00 million in debt, with a net cash position of 1.91 billion or 55.97 per share.

Cash & Cash Equivalents	2.69B
Total Debt	786.00M
Net Cash	1.91B
Net Cash Per Share	55.97
Equity (Book Value)	2.70B
Book Value Per Share	79.21
Working Capital	4.39B

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 87.81%, with operating and profit margins of -23.55% and -28.82%.

Gross Margin	87.81%
Operating Margin	-23.55%
Pretax Margin	-28.62%
Profit Margin	-28.82%
EBITDA Margin	-20.12%
EBIT Margin	-23.55%
FCF Margin	n/a

Dividends & Yields

Stella Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.11%
Shareholder Yield	-4.11%
Earnings Yield	-1.74%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Stella Pharma has an Altman Z-Score of 4.64 and a Piotroski F-Score of 3.

Altman Z-Score	4.64
Piotroski F-Score	3